Futuremeds Sp. z o.o.

Research site

Poland Ul. Pulawska 17, 02-515 Warsaw, Poland

2 trials recruiting
Generalised tonic-clonic seizure · Hepatic cirrhosis · Metabolic dysfunction-associated steatohepatitis
Adult patients

About Specializations

Futuremeds Sp. z o.o. in Warsaw, Poland specialises in clinical trials of conditions such as Generalised tonic-clonic seizure, Hepatic cirrhosis, Metabolic dysfunction-associated steatohepatitis, Non-alcoholic steatohepatitis, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ul. Pulawska 1702-515 WarsawPoland

Open in maps ↗

Recruiting now: 2 trials
Conditions studied: 5

More sites in Warsaw Poland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Hepatic cirrhosis+2

Recruiting

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Efruxifermin
Sponsor:Akero Therapeutics Inc.

Contact Research Centre

Generalised tonic-clonic seizure+1

Recruiting

Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

InvestigationalNo placebo

Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:PRAX-628
Sponsor:Praxis Precision Medicines Inc.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites